Screening of Down’s Syndrome in the 10th-13th Weekof Gestation
D. Stejskal 1; jun. M. Břešťák 2; M. Hostlovská 3
Oddělení lékařské genetiky GENNET, Poliklinika Klimentská, Praha 2 Gyncentrum Sanatorium, Hloubětínská 3, Praha 9 3 VFN ÚKB-laboratoř, Poliklinika Klimentská, Praha
Čes. Gynek.1999, , č. 5 s. 309-312
The implementation of antenatal screening for Down’s syndrome at 10-13. week usingnuchal translucency, maternal serum free subunit of human chorionic gonadotrophin and themother’s age.Design: Nuchal translucency scan (NT) and serum free beta human chorionic gonadotrophinsubunit (FB hCG) were measured at 283 consecutive pregnant women booked at the same antena-tal care facility between 10-13. gestational week.Setting: Antenatal screening center Klimentska, Prague.Methods: Medians of both markers according to gestational age as well as retrospective combinedrisk of Down’s syndrome were assessed.Results: 95 per cent of NT measurements was below 1.77 multiples of median. 95 per cent of FBhCG measurements was below 1.88 multiples of median. Combined risk higher than 1/300 had1 per cent mothers (total 3 screen positive results).Conclusion: The results of this pilot study serve for implementation of screening for Down’ssyndrome at 10-13. week as well as for integration of both first and second trimester screeningsystems.
first trimester, nuchal translucency, free beta hCG, screening for Down’s syndrome
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP
Gynaecology and obstetrics